TNFSF10 and glioblastoma: These studies demonstrated that 5 × 106 cell per mL of hydrogel was the optimal cell density to maintain > 80% cell viability following encapsulation, to efficiently secrete therapeutic levels of TRAIL (>50 ng/mL), and to effectively kill > 50% of the GBM cells in vitro within 72 h [27].